Pre-CAAP Company: Ourotech Presents at Wall Street Journal Conference & Featured on the WSJ Website

OBIO News
Written By Guest User

Ourotech's CEO Duleeka Ranatunga presented their novel cancer drug screening technology at the WSJ.D Conference last week.

Their pitch is featured on the Wall Street Journal website here

Guest User
Previous

CAAP Company: Medella Health Community Diabetes Survey
Next

CAAP Company: Komodo OpenLabs Featured on BNN's The Disruptors